Added to YB: 2025-09-09
Pitch date: 2025-07-23
FEMY [bullish]
Femasys Inc.
-36.51%
current return
Author Info
No bio for this author
Company Info
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally.
Market Cap
$30.2M
Pitch Price
$0.86
Price Target
4.17 (+664%)
Dividend
N/A
EV/EBITDA
-2.07
P/E
-0.76
EV/Sales
16.51
Sector
Health Care Equipment and Supplies
Category
growth
Femasys Inc. - $FEMY
FEMY: Medtech platform for women's reproductive health w/ 4 FDA-cleared products. FemaSeed (fertility) launched w/ 24% pregnancy rate vs 6.7% IUI. FemBloc (contraception) CE-marked, US pivotal trial underway, targets $2B+ TAM w/ no competitor. Near-term liquidity risk w/ convert due Nov but 5x+ upside potential.
Read full article (8 min)